INTERNATIONAL 3D HYDROGEL AND BIOINK MANUFACTURER, BIOGELX, HAS ANNOUNCED THE APPOINTMENT OF A NEW CHAIRMAN. The company’s Board of Directors have unanimously elected John Waddell to succeed retiring Chairman, Douglas Hutchison who has stepped down from the role after supporting Biogelx since they were established in 2013. “It’s been an honour to work with the Biogelx team over the past six years and see the company evolve...
CPI has created a cutting-edge, next generation system to drive efficient learning for complex particle products. CPI, along with the expert input of its partners, has successfully coupled together two of its core projects – Models MPP and Prospect CP – to develop a novel, accessible Digital Twin. This facility creates an open-access learning environment to work against the challenges of powder mixing and granulation...
Lamellar Biomedical Limited (Lamellar), an innovative biotechnology company, pioneering new approaches for the safe and effective transfer of functional nucleic acids, announces two research partnerships to further optimise its LAMELLASOME™ Nucleic Acid technology platform and its product manufacturing processes. The partnerships are with the University of Strathclyde and Edinburgh University. Lamellar believes its LAMELLASOME NAT (Nucleic Acid Transfer) technologywill play a key role in realising the...
REPROCELL will provide custom drug discovery assays using live human tissues to improve the prediction of drug safety and efficacy The collaboration is part of Medicines Discovery Catapult’s Virtual R&D network, which aims to support UK SMEs develop and execute their drug discovery projects with industrial rigour REPROCELL Europe Ltd (REPROCELL), a UK-based human tissue research company, announced a strategic partnership with Medicines Discovery Catapult....
The University of Dundee’s Drug Discovery Unit has announced a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration including Alzheimer’s disease. Tau pathology occurs when the normal cellular protein, tau, misfolds and forms insoluble fibrils. It is found in the brains of sufferers of more than 20 different neurodegenerative diseases, of...
NovaBiotics has been awarded £1.8 million in small business research innovation grant funding to advance its antifungal drug candidate, Novamycin. The drug is a first-in-class antifungal compound, intended for front-line treatment of medically unmet, tissue and bloodstream fungal infections caused by difficult to treat and drug resistant moulds and yeasts, including Aspergillus fumigates and Candida auris. Novamycin is highly differentiated from existing antifungal treatments – of which there...